Trading in the shares of Mega Genomics (HKG:6667) resumed Friday, according to a notification by the Hong Kong Stock Exchange.
Shares of the genetic testing and cancer screening services company were down over 8% in Friday afternoon trading.
The move came after the firm was able to fulfill all the resumption guidance set out by the bourse, according to a Thursday filing by the firm.
Trading in the firm's shares had previously been suspended since April 1, 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.